Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.63 USD | +1.24% | +11.64% | +10.88% |
Mar. 13 | Transcript : Spero Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024 | |
Mar. 13 | Spero Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | 48.23M | Sales 2025 * | 47.83M | Capitalization | 87.85M |
---|---|---|---|---|---|
Net income 2024 * | -53M | Net income 2025 * | -62M | EV / Sales 2024 * | 1.82 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.84 x |
P/E ratio 2024 * |
-1.74
x | P/E ratio 2025 * |
-1.71
x | Employees | 46 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 79.84% |
Latest transcript on Spero Therapeutics, Inc.
1 day | +1.24% | ||
1 week | +11.64% | ||
Current month | +14.79% | ||
1 month | -1.21% | ||
3 months | +13.19% | ||
6 months | +36.97% | ||
Current year | +10.88% |
Managers | Title | Age | Since |
---|---|---|---|
Satyavrat Shukla
CEO | Chief Executive Officer | 52 | 21-01-03 |
Ankit Mahadevia
FOU | Founder | 43 | 13-03-31 |
Esther Rajavelu
DFI | Director of Finance/CFO | 46 | Nov. 05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Frank Thomas
BRD | Director/Board Member | 54 | 17-06-30 |
John Pottage
BRD | Director/Board Member | 71 | 18-08-13 |
Scott Jackson
BRD | Director/Board Member | 59 | 20-04-15 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 1.63 | +1.24% | 92,863 |
24-05-02 | 1.61 | +4.21% | 301,896 |
24-05-01 | 1.545 | +8.80% | 281,998 |
24-04-30 | 1.42 | -1.39% | 95,314 |
24-04-29 | 1.44 | -1.37% | 170,558 |
Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.88% | 87.85M | |
+8.96% | 105B | |
-1.43% | 104B | |
+5.50% | 22.94B | |
-12.15% | 22.34B | |
-5.89% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- SPRO Stock